Back to today’s briefing

Story perspectives

UAE Launches Revolutionary Gene Therapy for Blood Disorders

3/31/2025

24 4

Summary

Story summary

The Abu Dhabi Department of Health has unveiled a groundbreaking CRISPR/Cas9 gene editing therapy in the UAE, specifically designed to combat sickle cell disease and transfusion-dependent beta-thalassemia. By extracting and genetically modifying stem cells for reimplantation, this innovative treatment, now approved for patients aged 12 and older, promises to revolutionize healthcare in the region.

1 of 1

Story summary

The Abu Dhabi Department of Health has unveiled a groundbreaking CRISPR/Cas9 gene editing therapy in the UAE, specifically designed to combat sickle cell disease and transfusion-dependent beta-thalassemia. By extracting and genetically modifying stem cells for reimplantation, this innovative treatment, now approved for patients aged 12 and older, promises to revolutionize healthcare in the region.